HAIFA BAY, Israel (AP) _ Taro Pharmaceutical Industries Ltd. (TARO) on Wednesday reported fiscal fourth-quarter earnings of $58.4 million.
On a per-share basis, the Haifa Bay, Israel-based company said it had profit of $1.52.
The drug maker posted revenue of $179.9 million in the period.
For the year, the company reported profit of $281.8 million, or $7.23 per share. Revenue was reported as $669.9 million.
Taro shares have risen 21% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $102.13, a decrease of 9% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TARO at https://www.zacks.com/ap/TARO